MRVI
What one share of Maravai LifeSciences Holdings holds
Pharmaceutical Preparations
Maravai LifeSciences Holdings, Inc. (also referred to in this document as “Maravai,” “we,” “us,” “our” or “the Company”) is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease.
Maravai LifeSciences Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.43 |
|---|---|
| Profit | −$0.53 |
| Capex (buildings and equipment) | $0.07 |
| Free cash flow | −$0.25 |
| Cash and investments | $0.47 |
| Debt | $1.19 |
| Book value | $1.38 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $0.56 | −$0.03 | $0.07 | $0.03 | — | $0.57 |
| 2020 | $9.83 | $2.36 | $0.88 | $4.39 | — | — |
| 2021 | $3.10 | $1.56 | $0.06 | $1.37 | — | — |
| 2022 | $3.46 | $1.67 | $0.07 | $2.03 | — | $4.14 |
| 2023 | $2.19 | −$0.90 | $0.50 | $0.46 | — | $3.16 |
| 2024 | $1.88 | −$1.05 | $0.22 | −$0.16 | — | $2.36 |
| 2025 | $1.29 | −$0.91 | $0.09 | −$0.49 | — | $1.47 |